Register
Community
Physicians
Editors
Experts
Code of conduct
Blog
Company
About
Publications
Press
Careers
Programs
Journal Club
Targeted Topic
Clinical Trial
Tumor Board
Contact Us
Sign in
Topics:
Medical Oncology
•
Thrombosis
•
Hematology
•
Benign Hematology
•
Hemostasis/Thrombosis
Would you anticoagulate an SMV thrombosis caused by malignant obstruction in the setting of metastatic colorectal cancer?
Related Questions
How do you determine duration of anticoagulation for an ovarian vein thrombosis following a provoking event?
How long should a patient with COVID-19 vaccine-induced thrombotic thrombocytopenia be treated with anticoagulation?
What is your preferred anticoagulant for acute portal vein thrombosis?
Are you comfortable using DOACs in obese patients with VTE?
How do you advise a patient with VTE on indefinite anticoagulants regarding the Ad26.COV2.S Johnson & Johnson/Janssen COVID vaccine?
How would you manage VTE in a patient with bleeding disorder such as hemophilia?
In the rare setting of enoxaparin injection-induced abdominal wall hematoma in patients requiring long-term anticoagulation, what is your timeline for restarting anticoagulation?
In patients who develop a VTE, what conditions do you consider as persistent, provoking risk factors, and at what point are they controlled enough to stop anticoagulation?
Is there any data for dose adjustment of apixaban in patients that have undergone bowel resection?
What is the anticoagulation recommendation for a chronic DVT?
